Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG7-CART in MG7-positive liver metastases
NCT02862704Phase 2Unknown
- Sponsor
- Xijing Hospital
- Start
- Jun 2016
- Primary completion
- May 2017
- Countries
- 1
01
Overview
A Phase 2 trial of MG7-CART in liver metastases, sponsored by Xijing Hospital. Status: unknown.
02
Drugs
MG7-CART
03
Conditions
liver metastases
Beyond the preview
Go deeper on NCT02862704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862704.